|
市場調査レポート
商品コード
1401210
パルスオキシメーターの世界市場規模、シェア、産業動向分析レポート:エンドユーザー別、タイプ別、地域別展望と予測、2023年~2030年Global Pulse Oximeter Market Size, Share & Industry Trends Analysis Report By End User (Hospitals & Clinics, Homecare and Others), By Type (Fingertip, Handheld, Wrist worn, Bedside, and Others), By Regional Outlook and Forecast, 2023 - 2030 |
||||||
パルスオキシメーターの世界市場規模、シェア、産業動向分析レポート:エンドユーザー別、タイプ別、地域別展望と予測、2023年~2030年 |
出版日: 2023年12月21日
発行: KBV Research
ページ情報: 英文 275 Pages
納期: 即納可能
|
世界のパルスオキシメーター市場規模は、予測期間中にCAGR 6.3%で成長し、2030年までには34億米ドルに達すると予測されます。2022年の市場規模は1,404万3,600個となり、18.0%(2019年~2022年)の成長を遂げています。
さらに、パンデミックは、特に呼吸器症状がCOVID-19患者の主な懸念事項であった初期段階において、パルスオキシメーターの需要の急増につながりました。個人やヘルスケア施設は、自宅や臨床現場で酸素濃度をモニターするためにこれらの機器を求めました。COVID-19患者のかなりの割合が中等度の症状を示すか無症状であったため、在宅モニタリングの普及が進みました。パルスオキシメーターは、患者が自己監視するためにも、ヘルスケア専門家が患者の酸素濃度を遠隔で追跡するためにも不可欠なものとなりました。需要の高まりは、市場での技術革新と製品開拓を促しました。ヘルスケアメーカー各社は、医療従事者や消費者の進化するニーズに応えるため、新たな機能や技術を模索しました。そのため、COVID-19の流行は市場にプラスの影響を与えました。
しかし、高いヘルスケア・インフラと認知度を特徴とする新興国市場では、特定の医療機器に対する需要が飽和状態に達することが多いです。このような成熟市場では、対象人口の大部分がすでにパルスオキシメーターを所有しているか、入手可能である可能性があり、市場拡大の新たな機会が制限されます。先進地域ではパルスオキシメーターが広く普及しているため、普及率は高いです。ヘルスケア施設や個人を含む人口の多くがすでにこれらの機器を持っている可能性があり、追加販売の可能性が低くなります。例えば、呼吸器健康モニタリングだけでなく、スポーツやフィットネス用途に拡大したり、パルスオキシメーターをウェアラブル機器に統合したりすることで、新たなユーザー層を惹きつけることができるかもしれません。こうした側面が市場の成長を抑制する可能性があります。
エンドユーザーの展望
エンドユーザーに基づき、市場は病院・診療所、在宅ケア、その他に区分されます。2022年には、在宅ケア分野が市場で大きな収益シェアを獲得しました。患者の利便性、経済効率、慣れ親しんだ環境で慢性疾患を管理する能力などの要因によって、自宅でヘルスケアを提供する動きが広がっています。パルスオキシメーターは、自宅で酸素濃度をモニターするための実用的かつ非侵入的な方法を提供します。世界の人口の高齢化により、慢性呼吸器疾患やその他の様々な健康合併症の発生率が増加しています。特に高齢者は、自宅で酸素飽和度レベルをモニターすることで恩恵を受ける可能性があり、この層でパルスオキシメーターの採用が増加しています。したがって、このセグメントは今後数年で急速に拡大すると思われます。
タイプの展望
タイプ別に見ると、市場はハンドヘルド型、指先型、手首装着型、ベッドサイド型、その他に分けられます。2022年には、指先セグメントが市場で最大の収益シェアを占めました。特にパンデミック時の遠隔患者モニタリングの普及が、指先パルスオキシメーターの普及に貢献しました。患者はこれらのデバイスを自宅で簡単に使用でき、データはヘルスケアプロバイダーに送信され、遠隔モニタリングと介入が可能になります。このような点から、このセグメントの需要は増加すると考えられます。
地域の展望
地域別に見ると、市場は北米、欧州、アジア太平洋、ラテンアメリカ、中東、アフリカに区分されます。北米セグメントは、2022年の市場で最も高い収益シェアを獲得しました。北米、特に米国は、世界的に見ても最もヘルスケア支出が多い国のひとつです。確立されたヘルスケアインフラと医療技術への多額の投資が、パルスオキシメーターのような先進医療機器の採用に寄与しています。こうした側面が、この分野に有利な成長見通しをもたらすと思われます。
The Global Pulse Oximeter Market size is expected to reach $3.4 billion by 2030, rising at a market growth of 6.3% CAGR during the forecast period. In the year 2022, the market attained a volume of 14,043.6 thousand units, experiencing a growth of 18.0% (2019-2022).
Pulse oximeters offer a user-friendly tool for patients to monitor their oxygen levels at home, fostering a sense of control and early intervention. Therefore, the Homecare segment acquired $690.8 million in 2022. Pulse oximeters provide a non-invasive and immediate way to measure oxygen saturation levels, enabling patients and healthcare professionals to monitor respiratory health regularly. Patients are increasingly becoming proactive in managing their health, and awareness campaigns have empowered individuals to take charge of their respiratory well-being. Some of the factors impacting the market are increasing remote patient monitoring, rising aging population around the world, and increasing saturation in various nations.
Home healthcare allows individuals, especially those with chronic conditions, to monitor their health without frequent visits to healthcare facilities. Pulse oximeters offer a convenient and accessible way for individuals to track their oxygen levels in the comfort of their homes. Patients with chronic respiratory conditions, such as COPD and asthma, often require continuous monitoring of their oxygen saturation levels. Home use of pulse oximeters facilitates regular monitoring, enabling individuals and their healthcare providers to manage chronic conditions more effectively. Additionally, respiratory conditions, such as chronic obstructive pulmonary disease (COPD), pneumonia, and other lung diseases, become more prevalent with age. The aging process can affect lung function, making older individuals more susceptible to respiratory challenges. Aging individuals may not always exhibit obvious symptoms of respiratory problems until the conditions have progressed. Pulse oximeters provide a non-invasive and quick way to assess oxygen saturation levels, enabling early detection of potential respiratory issues before they become severe. Pulse oximeters support this preference by offering a tool for home monitoring. Seniors can regularly check their oxygen levels, promoting independence and proactive health management. These factors will drive the demand for pulse oximeters in the coming years.
Further, the pandemic led to a surge in demand for pulse oximeters, especially during the early stages when respiratory symptoms were a primary concern for COVID-19 patients. Individuals and healthcare facilities sought these devices to monitor oxygen levels at home and clinical settings. A considerable proportion of COVID-19 patients exhibited moderate symptoms or were asymptomatic, which contributed to the increasing prevalence of home monitoring. Pulse oximeters became essential for patients to self-monitor and for healthcare professionals to track patients' oxygen levels remotely. The increased demand prompted innovation and product development in the market. Manufacturers explored new features and technologies to meet the evolving needs of healthcare professionals and consumers. Therefore, the COVID-19 pandemic positively impacted the market.
However, developed markets, characterized by high healthcare infrastructure and awareness, often reach a saturation point for certain medical devices. In these mature markets, a large proportion of the target population may already own or have access to pulse oximeters, limiting new opportunities for market expansion. The widespread adoption of pulse oximeters in developed regions results in high penetration rates. Many of the population, including healthcare facilities and individuals, may already possess these devices, reducing the potential for additional sales. For example, expanding beyond respiratory health monitoring to sports and fitness applications or integrating pulse oximeters into wearable devices may attract new user segments. These aspects can restrain the growth of the market.
End User Outlook
Based on end user, the market is segmented into hospitals & clinics, homecare, and others. In 2022, the homecare segment garnered a significant revenue share in the market. A more extensive movement has emerged towards healthcare provided at home, motivated by factors such as patient convenience, financial efficiency, and the capacity to oversee chronic ailments in a familiar environment. Pulse oximeters offer a practical and non-intrusive method for monitoring oxygen levels in one's residence. The worldwide population is aging, leading to an increased incidence of chronic respiratory conditions and various other health complications. Older people, in particular, may benefit from monitoring their oxygen saturation levels at home, leading to increased adoption of pulse oximeters in this demographic. Therefore, the segment will expand rapidly in the coming years.
Type Outlook
On the basis of type, the market is divided into handheld, fingertip, wrist worn, bedside, and others. In 2022, the fingertip segment witnessed the maximum revenue share in the market. The growth of remote patient monitoring practices, especially during the pandemic, contributed to the popularity of fingertip pulse oximeters. Patients could easily use these devices at home, with the data transmitted to healthcare providers for remote monitoring and intervention. These aspects will lead to increased demand in the segment.
Regional Outlook
By region, the market is segmented into North America, Europe, Asia Pacific, and LAMEA. The North America segment procured the highest revenue share in the market in 2022. North America, particularly the United States, has one of the highest healthcare spending levels globally. The well-established healthcare infrastructure and significant investments in medical technology contribute to the adoption of advanced medical devices like pulse oximeters. These aspects will pose lucrative growth prospects for the segment.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Hill-Rom Holdings, Inc. (Welch Allyn) (Baxter International, Inc.), GE HealthCare Technologies, Inc., Koninklijke Philips N.V., Nonin Medical, Inc., ICU Medical, Inc. (Smiths Medical), Medtronic PLC, OSI Systems, Inc. (Spacelabs Healthcare), Nihon Kohden Corporation, Meditech Equipment Co.,Ltd (Meditech Group), and Honeywell International, Inc.
Market Segments covered in the Report:
By End User (Volume, Thousand Units, USD billion, 2019-2030)
By Type (Volume, Thousand Units, USD billion, 2019-2030)
By Geography (Volume, Thousand Units, USD billion, 2019-2030)
Companies Profiled
Unique Offerings from KBV Research